Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...

Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma (HCC)—the most common type ...

Merck and Eisai halt late-stage trial as Keytruda/Lenvima combo fails to improve survival in liver cancer. Read more here.

Chinese researchers have revealed a mechanism that triggers metastasis of hepatocellular carcinoma through the production of ...

Patients enrolled had NET liver metastases of any grade or origin that were progressive, symptomatic, or represented a high ...

Dr. Anjana Pillai explains that staging liver cancer involves assessing tumor size, spread, and vessel involvement to guide ...

A Shropshire woman with a deadly cancer has been fundraising for life-extending treatment through bake sales. NHS worker ...

BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

A cancer patient who works at the NHS is trying to raise £120,000 for chemotherapy after she was refused the treatment. Jamie ...

A TIKTOKER battling cancer paid a heartbreaking tribute to her husband and spoke about her future plans in a post shared ...